deltatrials
Terminated PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT02011542

Probiotic (VSL #3) for Gulf War Illness

Probiotics (VSL #3) for Gulf War Illness

Sponsor: United States Department of Defense

Conditions Gulf War Illness
Interventions Placebo VSL#3
Updated 11 times since 2017 Last updated: Oct 24, 2018 Started: Sep 30, 2013 Primary completion: Jul 31, 2016 Completion: Jul 31, 2016
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Original study product (VSL #3) became unavailable; change in study Collaborator and product

Other terminated trials from United States Department of Defense

See all terminations from United States Department of Defense

Other Gulf War Illness trials with similar outcome

Browse all Gulf War Illness trials

This PHASE2/PHASE3 trial investigates Gulf War Illness and is currently terminated or withdrawn. United States Department of Defense leads this study, which shows 11 recorded versions since 2013 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotRecruiting~Feb 2017 – ~May 2017 · 3 months · monthly snapshotRecruiting~May 2017 – ~Aug 2017 · 3 months · monthly snapshotTerminated~Aug 2017 – ~Feb 2018 · 6 months · monthly snapshotTerminated~Feb 2018 – ~Jun 2018 · 4 months · monthly snapshotTerminated~Jun 2018 – ~Nov 2018 · 5 months · monthly snapshotTerminated~Nov 2018 – ~Jan 2021 · 26 months · monthly snapshotTerminated~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshotTerminated~Dec 2021 – ~Jul 2024 · 31 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

11 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE2/PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE2/PHASE3

    Phase: PHASE2_PHASE3 → PHASE2/PHASE3

  3. Dec 2021 — Jul 2024 [monthly]

    Terminated PHASE2_PHASE3

  4. Jan 2021 — Dec 2021 [monthly]

    Terminated PHASE2_PHASE3

  5. Nov 2018 — Jan 2021 [monthly]

    Terminated PHASE2_PHASE3

▶ Show 6 earlier versions

  1. Jun 2018 — Nov 2018 [monthly]

    Terminated PHASE2_PHASE3

  2. Feb 2018 — Jun 2018 [monthly]

    Terminated PHASE2_PHASE3

  3. Aug 2017 — Feb 2018 [monthly]

    Terminated PHASE2_PHASE3

  4. May 2017 — Aug 2017 [monthly]

    Terminated PHASE2_PHASE3

    Status: Recruiting → Terminated

  5. Feb 2017 — May 2017 [monthly]

    Recruiting PHASE2_PHASE3

  6. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE2_PHASE3

    First recorded

Sep 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • United States Department of Defense
  • University of Utah
Data source: University of Utah

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations